MARK MOORE: Open Payments
NPI 1962489567 · MERIDIAN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$916 in 36 payments from 12 companies in 2025. Trend: 2023 $592 · 2024 $435 · 2025 $916
Food & beverage: $916
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $185 |
| Boston Scientific Corporation | 1 | $139 |
| PFIZER INC. | 9 | $138 |
| Lilly USA, LLC | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 6 | $97 |
| Merck Sharp & Dohme LLC | 4 | $90 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| E.R. Squibb & Sons, L.L.C. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $18 |
Products named: Varithena Administration Pack, MICRA, ZEPBOUND, LEQVIO, SYMPLICITY G3, Kerendia, VYNDAQEL, VERQUVO.
Industry payments across MS — which companies pay providers there.
